STOCK TITAN

SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

SeaStar Medical Holding Corporation approved cash and stock retention bonuses for executives Eric Schlorff and Kevin Chung under a 2026 Retention Bonus Program. Schlorff’s bonus totals $200,000 and Chung’s totals $140,000, each split into three equal installments.

Each one-third payment is scheduled for July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued employment on each vesting date. Executives will also receive an additional amount equal to 25% of each payment in shares of common stock under the 2022 Omnibus Incentive Plan, based on the closing share price on each vesting date.

If an executive departs before a vesting date, remaining payments are forfeited, while a separation without cause provides a pro‑rated amount of the next payment. The company executed individual 2026 Retention Bonus Program Agreements with both executives, filed as exhibits to this report.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Total bonus - Eric Schlorff $200,000 Retention bonus under 2026 Retention Bonus Program
Total bonus - Kevin Chung $140,000 Retention bonus under 2026 Retention Bonus Program
Each 1/3 payment - Schlorff $66,666 Per‑installment cash portion of retention bonus
Each 1/3 payment - Chung $46,666 Per‑installment cash portion of retention bonus
Stock value per 1/3 payment - Schlorff $16,666.50 Value of restricted stock for each installment
Stock value per 1/3 payment - Chung $11,666.50 Value of restricted stock for each installment
Stock portion rate 25% of each payment Paid in common stock based on closing share price
retention bonuses financial
"approved retention bonuses for each of Eric Schlorff and Kevin Chung"
2022 Omnibus Incentive Plan financial
"shares of the Company’s common stock under the Company’s 2022 Omnibus Incentive Plan"
separated from the Company without cause financial
"If an Executive is separated from the Company without cause, he will receive a pro-rata amount"
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Retention Bonus Program Agreement financial
"entered into a 2026 Retention Bonus Program Agreement with each of the Executives"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What executive retention bonuses did ICU approve in this 8-K?

SeaStar Medical approved retention bonuses of $200,000 for Eric Schlorff and $140,000 for Kevin Chung. Each bonus is paid in three installments with an added stock component equal to 25% of each payment.

How and when do the ICU executive retention bonuses vest?

The retention bonuses vest in three equal parts on July 1, 2026, November 1, 2026, and March 1, 2027. Each installment requires the executive to remain employed through the applicable vesting date.

What portion of the ICU retention bonuses is paid in stock?

In addition to cash, each executive receives 25% of each installment in SeaStar Medical common stock. The number of shares is determined using the closing share price on each applicable vesting date under the 2022 Omnibus Incentive Plan.

What happens if an ICU executive leaves before a vesting date?

If an executive departs before a vesting date, no future retention bonus payments are made. If separated from the company without cause, he becomes entitled to a pro‑rated amount of the then current upcoming payment.
false 0001831868 0001831868 2026-06-25 2026-06-25 0001831868 icu:CommonStockCustomMember 2026-06-25 2026-06-25 0001831868 icu:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockFor1150PerShareCustomMember 2026-06-25 2026-06-25
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 25, 2026
 

 
SeaStar Medical Holding Corporation
 
(Exact name of Registrant as Specified in Its Charter)
 

 
Delaware
001-39927
85-3681132
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
     
3513 Brighton Blvd, Suite 410
 
Denver, Colorado
 
80216
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrants Telephone Number, Including Area Code: 844 427-8100
 
(Former Name or Former Address, if Changed Since Last Report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock par value $0.0001 per share
 
ICU
 
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
 
ICUCW
 
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 
 

 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On June 25, 2026, the Compensation Committee of the Board of Directors of the SeaStar Medical Holding Corporation (the “Company”) approved retention bonuses for each of Eric Schlorff and Kevin Chung (“Executives”) in the amount set forth below, (a) one-third of which will vest and be payable on July 1, 2026, (b) one-third of which will vest and be payable on November 1, 2026, and (c) one-third of which will vest and be payable on March 1, 2027, in each case subject to continued employment through the applicable vesting date. Executives will receive an additional amount equal to 25% of each payment in shares of the Company’s common stock under the Company’s 2022 Omnibus Incentive Plan, with the number of shares being determined based on the share price at the close of business on each applicable vesting date. If an Executive departs prior to the applicable vesting date, no future payments will be made. If an Executive is separated from the Company without cause, he will receive a pro-rata amount for the then current upcoming payment. These bonuses were part of a broader retention program affecting additional long-serving Company employees. On June 29, 2026, the Company entered into a 2026 Retention Bonus Program Agreement with each of the Executives (the “Agreements’). The foregoing description of the Agreements do not purport to be complete and are qualified in their entirety by reference to the Agreements, which are filed as Exhibit 10.1 and Exhibit 10.2 to this Current Report on Form 8-K and are incorporated herein by reference.
 
Executive   Retention Bonus Amount   Each 1/3 Payment    Value of Restricted Stock For Each 1/3 Payment
Eric Schlorff   $200,000   $66,666   $16,666.50
Kevin Chung   $140,000   $46,666   $11,666.50
 
 
 
Item 9.01 Financial Statements and Exhibits.
 
Exhibit No.
 
Description
10.1
 
2026 Retention Bonus Program Agreement between the Company and Eric Schlorff, dated June 29, 2026
10.2
 
2026 Retention Bonus Program Agreement between the Company and Kevin Chung, dated June 29, 2026
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
SeaStar Medical Holding Corporation
 
   
By:
/s/ Eric Schlorff
Date:
July 1, 2026
Name:
Eric Schlorff
   
Title:
Chief Executive Officer
 
 

Filing Exhibits & Attachments

6 documents